JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB137398

Anti-PLK4 antibody

1

(1 Review)

|

(12 Publications)

Rabbit Polyclonal PLK4 antibody. Suitable for ICC/IF and reacts with Human samples. Cited in 12 publications. Immunogen corresponding to Recombinant Fragment Protein within Human PLK4 aa 600-900.

View Alternative Names

SAK, STK18, PLK4, Serine/threonine-protein kinase PLK4, Polo-like kinase 4, Serine/threonine-protein kinase 18, Serine/threonine-protein kinase Sak, PLK-4

1 Images
Immunocytochemistry/ Immunofluorescence - Anti-PLK4 antibody (AB137398)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-PLK4 antibody (AB137398)

Immunofluorescence analysis of methanol-fixed HeLa cells labelled with ab137398 at 1/500 dilution (Green). Alpha-tubulin filaments labeled (Red).

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

ICC/IF

applications

Immunogen

Recombinant Fragment Protein within Human PLK4 aa 600-900. The exact immunogen used to generate this antibody is proprietary information.

O00444

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "1/100 - 1/1000", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100 - 1/1000", "ICCIF-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7 Preservative: 0.025% Proclin 300 Constituents: PBS, 20% Glycerol (glycerin, glycerine), 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Serine/threonine-protein kinase that plays a central role in centriole duplication. Able to trigger procentriole formation on the surface of the parental centriole cylinder, leading to the recruitment of centriole biogenesis proteins such as SASS6, CPAP, CCP110, CEP135 and gamma-tubulin. When overexpressed, it is able to induce centrosome amplification through the simultaneous generation of multiple procentrioles adjoining each parental centriole during S phase. Phosphorylates 'Ser-151' of FBXW5 during the G1/S transition, leading to inhibit FBXW5 ability to ubiquitinate SASS6. Its central role in centriole replication suggests a possible role in tumorigenesis, centrosome aberrations being frequently observed in tumors. Also involved in deuterosome-mediated centriole amplification in multiciliated that can generate more than 100 centrioles. Also involved in trophoblast differentiation by phosphorylating HAND1, leading to disrupt the interaction between HAND1 and MDFIC and activate HAND1. Phosphorylates CDC25C and CHEK2. Required for the recruitment of STIL to the centriole and for STIL-mediated centriole amplification (PubMed : 22020124). Phosphorylates CEP131 at 'Ser-78' and PCM1 at 'Ser-372' which is essential for proper organization and integrity of centriolar satellites (PubMed : 30804208).
See full target information PLK4

Publications (12)

Recent publications for all applications. Explore the full list and refine your search

The Prostate 82:957-969 PubMed35333404

2022

PLK4 is upregulated in prostate cancer and its inhibition reduces centrosome amplification and causes senescence.

Applications

Unspecified application

Species

Unspecified reactive species

Chandra K Singh,Ryan A Denu,Minakshi Nihal,Maria Shabbir,Debra R Garvey,Wei Huang,Kenneth A Iczkowski,Nihal Ahmad

IUBMB life 72:2627-2636 PubMed33031637

2020

Silencing of long non-coding RNA DLX6-AS1 weakens neuroblastoma progression by the miR-513c-5p/PLK4 axis.

Applications

Unspecified application

Species

Unspecified reactive species

Peisheng Jia,Erhu Wei,Huiqiong Liu,Tingting Wu,Huaili Wang

Scientific reports 10:11921 PubMed32681070

2020

Analysis of the "centrosome-ome" identifies MCPH1 deletion as a cause of centrosome amplification in human cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Ryan A Denu,Mark E Burkard

Journal of cellular and molecular medicine 24:3931-3947 PubMed32126150

2020

Inhibition of PLK4 might enhance the anti-tumour effect of bortezomib on glioblastoma via PTEN/PI3K/AKT/mTOR signalling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Jing Wang,Dengpeng Ren,Yan Sun,Chao Xu,Chunhong Wang,Rui Cheng,Lina Wang,Guijun Jia,Jinrui Ren,Jiuhong Ma,Yue Tu,Hongming Ji

Cancer medicine 8:6476-6484 PubMed31489978

2019

A cis-eQTL genetic variant in PLK4 confers high risk of hepatocellular carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Lijuan Meng,Yan Zhou,Sihan Ju,Jing Han,Ci Song,Jing Kong,Yifei Wu,Shuai Lu,Jiani Xu,Wenwen Yuan,Erbao Zhang,Cheng Wang,Zhibin Hu,Yayun Gu,Rongcheng Luo,Xuehao Wang

Cell death & disease 10:570 PubMed31358734

2019

Cep131 overexpression promotes centrosome amplification and colon cancer progression by regulating Plk4 stability.

Applications

Unspecified application

Species

Unspecified reactive species

Dong Hyun Kim,Jong Seog Ahn,Ho Jin Han,Hye-Min Kim,Joonsung Hwang,Kyung Ho Lee,Hyunjoo Cha-Molstad,In-Ja Ryoo,Jae-Hyuk Jang,Sung-Kyun Ko,Jin Ok Yang,Hee Gu Lee,Sangku Lee,Eun Joo Song,Jin Young Kim,Yang Hoon Huh,Yong Tae Kwon,Nak-Kyun Soung,Bo Yeon Kim

Proceedings of the National Academy of Sciences of 116:11309-11318 PubMed31097597

2019

Role for polo-like kinase 4 in mediation of cytokinesis.

Applications

Unspecified application

Species

Unspecified reactive species

Michael F Press,Bin Xie,Simon Davenport,Yu Zhou,Roberta Guzman,Garry P Nolan,Neil O'Brien,Michael Palazzolo,Tak W Mak,Joan S Brugge,Dennis J Slamon

Oncology reports 41:2159-2167 PubMed30816483

2019

Polo‑like kinase 4 promotes tumorigenesis and induces resistance to radiotherapy in glioblastoma.

Applications

Unspecified application

Species

Unspecified reactive species

Jia Wang,Jie Zuo,Maode Wang,Xudong Ma,Ke Gao,Xiaobin Bai,Ning Wang,Wanfu Xie,Hao Liu

Molecular medicine reports 18:5327-5336 PubMed30365085

2018

High LIN28A and PLK4 co‑expression is associated with poor prognosis in epithelial ovarian cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Yao He,Hui Wang,Meina Yan,Xinxin Yang,Rong Shen,Xiaoge Ni,Xiaokun Chen,Peifang Yang,Miao Chen,Xiaodong Lu,Genbao Shao,Xiaoming Zhou,Qixiang Shao

Molecular cancer research : MCR 16:517-527 PubMed29330283

2018

Centriole Overduplication is the Predominant Mechanism Leading to Centrosome Amplification in Melanoma.

Applications

Unspecified application

Species

Unspecified reactive species

Ryan A Denu,Maria Shabbir,Minakshi Nihal,Chandra K Singh,B Jack Longley,Mark E Burkard,Nihal Ahmad
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com